FreeObituary Michael Bishop, Nobel-winning cancer researcher, dies at 90 March 27, 2026Vol.52 No.12By UCSF Communications Staff
Sponsored Beyond the lab: Engineering collaboration in modern cancer research March 27, 2026Vol.52 No.12
Sponsored Machine-learning tool may predict serious transplant complications months before symptoms appearBlood biomarkers power a new AI-based approach to identifying risk after transplant March 27, 2026Vol.52 No.12
NCI Hoping to hit a $200M target, NCI and FNIH develop a plan for advancing cancer vaccinesNCI Director Letai: “How aggressive can we be?” March 20, 2026Vol.52 No.11By Claire Marie Porter
NCI A new working group will conduct site visits and advise NCAB and NCI director on cancer center grants March 20, 2026Vol.52 No.11By Paul Goldberg
NCI Letai: “From this point forward, it really is much more like business as usual at the NCI.” March 20, 2026Vol.52 No.11By Jacquelyn Cobb
Sponsored Early-onset colorectal cancer demands a new research playbook March 20, 2026Vol.52 No.11By Marwan Fakih
Conversation with The Cancer LetterFree Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.” March 13, 2026Vol.52 No.10By Paul Goldberg
Regulatory News Vinay Prasad, oncology’s gadfly-turned-CBER-director, will leave FDA (again) March 13, 2026Vol.52 No.10By Claire Marie Porter
Regulatory News Prasad’s rule by fiat spilled into accelerated approvals in hematology and oncologyAtara Bio’s Cokey Nguyen: Normally, FDA wants to help us succeed. Now, “we’re getting new guidance at the last minute and it’s not helping.” March 13, 2026Vol.52 No.10By Jacquelyn Cobb
